Page 3 - Frazier Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

J P Morgan Leads $100M Financing for Startup s R&D of Covalent Biologic Drugs for Cancer

J P Morgan Leads $100M Financing for Startup s R&D of Covalent Biologic Drugs for Cancer
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United statesLa jollaSan franciscoAl iskandariyahSergio duronScripps research instituteUniversity of californiaFrazier life sciencesBregua corporationScripps researchAvalon venturesLightspeed venture partnersAmgen venturesRegeneron venturesPappas capitalAlexandria venture

Enlaza Therapeutics Raises $100M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Al iskandariyahShelley chuStephen squintoJamie topperSergio duronJay lichterMarcos millaFrazier life sciencesLife sciencesBregua corporationEnlaza therapeuticsAsset managementPrivate capitalAvalon venturesLightspeed venture partnersSamsara biocapital

Enlaza gets JP Morgan, Regeneron backing for covalent biologics

BioPharma

Al iskandariyahSergio duronFrazier life sciencesEnlaza therapeuticsSan diego basedAmgen venturesAlexandria venture investmentsAvalon ventures

Form 8-K VERTEX PHARMACEUTICALS For: Apr 10

Form 8-K VERTEX PHARMACEUTICALS For: Apr 10
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan billerFrazier life sciences public fundCompany proposalFrazier life sciencesExchange commissionVertex pharmaceuticals incorporatedAdams merger sub incAlpine immune sciences incCompany material adverse effectSecurities exchangeCorporation lawDecheng capital global healthcare fund masterDecheng capital china life sciencesOrbimed genesis master fundSecurities exchange act

Arcutis Appoints David Topper as Chief Financial Officer

Industry veteran with over 40 years of experience in finance, investment management, and investment bankingWESTLAKE VILLAGE, Calif., April 10, 2024 Arcutis Biotherapeutics, Inc. , a.

Amanda sheldonLatha vairavanFrank watanabeJohn smitherDavid topperDerek coleArcutis biotherapeutics incCommitments committeeFrazier life sciencesDuke universityFrazier life sciences acquisition corpInvestor relations advisory solutionsExchange commissionMorgan stanleyStanford universityHead of corporate communications